Showing results (211-220 of 904) with videos related to

Sort By:
Pageof 91
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 22, 2011
Age-related differences in antithrombotic therapy, success rate and in-hospital mortality in patients undergoing percutaneous coronary intervention: results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)Arne Kristian Schwarz, Ralf Zahn, Matthias Hochadel, et al.
International Journal of Cardiology|May 16, 2019
Effect of renal insufficiency and diabetes mellitus on in-hospital mortality after acute coronary syndromes treated with primary PCI. Results from the ALKK PCI RegistrySpyridon Liosis, Matthias Hochadel, Harald Darius, et al.
European Journal of Heart Failure|June 7, 2014
Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trialGeorg Fuernau, Christian Poenisch, Ingo Eitel, et al.
The Cochrane Database of Systematic Reviews|March 28, 2015
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shockSusanne Unverzagt, Michael Buerke, Antoinette de Waha, et al.
The American Journal of Cardiology|December 16, 2014
Fifteen-year experience with carotid artery stenting (from the carotid artery stenting-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte)Nicolas Werner, Uwe Zeymer, Matthias Hochadel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 10, 2018
Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial [corrected]Amr Abdin, Janine Pöss, Georg Fuernau, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 2, 2018
Correction to: Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trialAmr Abdin, Janine Pöss, Georg Fuernau, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 22, 2018
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?D Duerschmied, J Brachmann, H Darius, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2017
Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trialMohammed Saad, Georg Fuernau, Steffen Desch, et al.
Journal of Interventional Cardiology|September 2, 2014
Cobalt-chromium KAname™ coRonary stEnt system in the treatment of patients with coronary artery disease (KARE study)Didier Carrie, Volker Schächinger, Gian Battista Danzi, et al.
Pageof 91